Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%

Healthcare

Page 51
  1. Mar 09, 2026 · 08:00 · NURS

    Hydreight Announces Normal Course Issuer Bid

    Hydreight Announces Normal Course Issuer Bid

    01
  2. Mar 09, 2026 · 07:30 · VHI

    VitalHub Announces Novari Health AI-Enhanced Referral Management Deployment

    VitalHub Announces Novari Health AI-Enhanced Referral Management Deployment

    02
  3. Mar 09, 2026 · 07:01 · TELO

    Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing

    Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing

    03
  4. Mar 09, 2026 · 07:01 · TLT

    Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer

    Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer

    04
  5. Mar 06, 2026 · 19:30 · NVRS

    Noveris Announces Conversion Of Debentures; Filing Of Early Warning Reports By JJK Holdings Ltd. And Joshua Bartch

    Noveris Announces Conversion Of Debentures; Filing Of Early Warning Reports By JJK Holdings Ltd. And Joshua Bartch

    05
  6. Mar 06, 2026 · 18:24 · WELL

    Well Health to release 2025 results March 19

    Well Health to release 2025 results March 19

    06
  7. Mar 06, 2026 · 17:20 · CYTO

    Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives

    Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives

    07
  8. Mar 06, 2026 · 16:24 · NVRS

    Noveris converts $8.18-million in debentures

    Noveris converts $8.18-million in debentures

    08
  9. Mar 06, 2026 · 10:13 · WELL

    WELL Health to Report Fourth Quarter and Year End 2025 Financial Results on March 19, 2026

    WELL Health to Report Fourth Quarter and Year End 2025 Financial Results on March 19, 2026

    09
  10. Mar 06, 2026 · 09:09 · AFV

    Apolo V Acquisition Corp. Announces Shareholder Approvals

    Apolo V Acquisition Corp. Announces Shareholder Approvals

    10
  11. Mar 05, 2026 · 21:01 · QIPT

    Quipt acquisition by Kingswood, Forager okayed by court

    Quipt acquisition by Kingswood, Forager okayed by court

    11
  12. Mar 05, 2026 · 20:50 · RKV

    Rakovina closes $1-million debenture unit financing

    Rakovina closes $1-million debenture unit financing

    12
  13. Mar 05, 2026 · 20:30 · QIPT

    Quipt Home Medical Receives Final Order Approving Arrangement

    Quipt Home Medical Receives Final Order Approving Arrangement

    13
  14. Mar 05, 2026 · 20:06 · RKV

    Rakovina Announces Closing of $1 Million Debenture Unit Private Placement and Debt Settlement Agreements

    Rakovina Announces Closing of $1 Million Debenture Unit Private Placement and Debt Settlement Agreements

    14
← Newer Older →